This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ pridinol methanesulfonate salt,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Muscle Relaxation: Pridinol acts centrally on the nervous system to induce muscle relaxation. It helps alleviate muscle spasms, stiffness, and tension, thereby improving mobility and reducing discomfort associated with musculoskeletal conditions.

  2. Antispasmodic Effects: Pridinol exerts antispasmodic effects by inhibiting the excessive contraction of muscles. It is particularly useful in the treatment of conditions characterized by abnormal or involuntary muscle contractions, such as muscle spasms, cramps, and dystonia.

  3. Pain Relief: By promoting muscle relaxation and reducing muscle spasms, pridinol can help alleviate associated pain symptoms. It may be used as an adjunctive therapy in the management of acute and chronic musculoskeletal pain conditions.

  4. Adjunctive Therapy: Pridinol is often used as an adjunctive therapy alongside other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, or physical therapy, to enhance the overall management of musculoskeletal disorders.

  5. Safety Profile: Pridinol is generally well-tolerated when used at recommended dosages. Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, and gastrointestinal disturbances. These side effects are usually mild and transient.

  6. Central Nervous System Effects: Due to its central nervous system activity, pridinol may cause sedation or drowsiness, particularly at higher doses. Patients should be advised to avoid activities requiring mental alertness, such as driving or operating heavy machinery, until they know how the medication affects them.

  7. Contraindications: Pridinol is contraindicated in individuals with a known hypersensitivity to the drug or its components. It should be used with caution in patients with certain medical conditions, such as glaucoma, urinary retention, or severe hepatic or renal impairment.

  8. Drug Interactions: Pridinol may interact with other medications that have sedative or CNS depressant effects, including alcohol, benzodiazepines, and opioids. Healthcare providers should assess potential drug interactions and adjust dosages accordingly when prescribing pridinol.

  9. Pregnancy and Lactation: The safety of pridinol use during pregnancy and lactation has not been well-established. Pregnant or breastfeeding women should consult their healthcare provider before using pridinol.

  10. Overdose: In cases of overdose or excessive ingestion of pridinol, symptoms may include severe CNS depression, respiratory depression, hypotension, and coma. Immediate medical attention is necessary if overdose is suspected.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of pridinol methanesulfonate salt,(prescription) On Probiotics

Rank Probiotic Impact
species Bacteroides uniformis Reduces
species Escherichia coli Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by pridinol methanesulfonate salt,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Phocaeicola genus Decreases
0 1 Bacteroides genus Decreases
0 1 Bilophila genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Escherichia genus Decreases
0 1 Segatella genus Decreases
0 1 Shigella genus Decreases
0 1 Roseburia genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Streptococcus genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Parabacteroides merdae species Decreases
1 0 Phocaeicola vulgatus species Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Escherichia coli species Decreases
1 0 Segatella copri species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Bacteroides humanifaecis species Decreases
1 0 Roseburia intestinalis species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Shigella boydii species Decreases
0 1 Bacteroides sp. A1C1 species Decreases
1 0 Mediterraneibacter gnavus species Decreases
0 1 Bacteroides sp. HF-162 species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Segatella bryantii species Decreases
0 1 Parabacteroides johnsonii species Decreases
0 1 Dysosmobacter welbionis species Decreases
0 1 Alistipes indistinctus species Decreases
0 1 Shigella sonnei species Decreases
0 1 Leyella stercorea species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Escherichia sp. E4742 species Decreases
1 0 Streptococcus parasanguinis species Decreases
0 1 Alistipes shahii species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Alistipes communis species Decreases
0 1 Coprococcus catus species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Streptococcus suis species Decreases
0 1 Alistipes senegalensis species Decreases
1 0 Streptococcus salivarius species Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of pridinol methanesulfonate salt,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 1 1
ADHD 1.4 1.4
Age-Related Macular Degeneration and Glaucoma 0.1 0.3 -2
Allergic Rhinitis (Hay Fever) 1.2 0.7 0.71
Allergies 2.2 1.1 1
Allergy to milk products 0.9 1 -0.11
Alopecia (Hair Loss) 0.4 0.4
Alzheimer's disease 3.8 2.6 0.46
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1 0.5 1
Ankylosing spondylitis 2.1 0.9 1.33
Anorexia Nervosa 0.3 1.2 -3
Antiphospholipid syndrome (APS) 1.4 0.3 3.67
Asthma 2.1 0.6 2.5
Atherosclerosis 1.9 0.4 3.75
Atrial fibrillation 1.3 1.8 -0.38
Autism 3.4 4.4 -0.29
Autoimmune Disease 0.5 0.1 4
Barrett esophagus cancer 0.3 0.1 2
benign prostatic hyperplasia 0.4 0.4 0
Biofilm 1.5 1.5
Bipolar Disorder 1.4 0.1 13
Brain Trauma 0.1 0.6 -5
Breast Cancer 1.2 1.2
Cancer (General) 0.3 0.3
Carcinoma 2.3 0.7 2.29
Celiac Disease 2.5 1 1.5
Cerebral Palsy 0.5 0.6 -0.2
Chronic Fatigue Syndrome 2.1 2.8 -0.33
Chronic Kidney Disease 1.4 0.6 1.33
Chronic Lyme 0.6 -0.6
Chronic Obstructive Pulmonary Disease (COPD) 1.1 0.5 1.2
Chronic Urticaria (Hives) 0.8 1 -0.25
Coagulation / Micro clot triggering bacteria 1.2 0.2 5
Cognitive Function 0.7 0.2 2.5
Colorectal Cancer 5 1.6 2.13
Constipation 1.4 0.1 13
Coronary artery disease 1.1 1.2 -0.09
COVID-19 4.4 3.7 0.19
Crohn's Disease 5.7 1.9 2
Cushing's Syndrome (hypercortisolism) 1 -1
cystic fibrosis 0.8 0.6 0.33
d-lactic acidosis (one form of brain fog) 0.5 0.5
deep vein thrombosis 2.2 0.6 2.67
Denture Wearers Oral Shifts 0.8 0.8
Depression 4.8 2.3 1.09
Dermatomyositis 0.1 0.1
Eczema 1 0.7 0.43
Endometriosis 1.7 0.6 1.83
Eosinophilic Esophagitis 0.3 0.1 2
Epilepsy 2.4 1.3 0.85
erectile dysfunction 1.2 1.2
Fibromyalgia 1 1.4 -0.4
Functional constipation / chronic idiopathic constipation 3.1 1.9 0.63
gallstone disease (gsd) 1.8 0.5 2.6
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 2.2 0.1 21
Generalized anxiety disorder 1.9 0.5 2.8
Glioblastoma 0.1 -0.1
Gout 0.5 0.2 1.5
Graves' disease 0.7 0.6 0.17
Gulf War Syndrome 0.1 1.2 -11
Halitosis 1.5 0.1 14
Hashimoto's thyroiditis 1.5 0.8 0.88
Heart Failure 2.5 0.1 24
hemorrhagic stroke 0.6 0.6
Hidradenitis Suppurativa 1.2 1.2
High Histamine/low DAO 0.6 0.6
hypercholesterolemia (High Cholesterol) 0.5 0.5
hyperglycemia 1 0.7 0.43
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 1.8 2.2 -0.22
Hypoxia 0.7 0.7
IgA nephropathy (IgAN) 1.1 2 -0.82
Inflammatory Bowel Disease 4.5 3.7 0.22
Insomnia 0.6 0.6 0
Intelligence 1.5 0.4 2.75
Intracranial aneurysms 1 1
Irritable Bowel Syndrome 3.4 2.1 0.62
ischemic stroke 1.2 1 0.2
Liver Cirrhosis 3 1.8 0.67
Long COVID 2.7 2.1 0.29
Low bone mineral density 0.1 -0.1
Lung Cancer 0.8 0.8
Lymphoma 0.4 0.4
Mast Cell Issues / mastitis 1.1 1.1
ME/CFS with IBS 0.1 0.5 -4
ME/CFS without IBS 0.2 0.9 -3.5
membranous nephropathy 0.1 0.1
Menopause 0.1 0.1 0
Metabolic Syndrome 3.9 3.4 0.15
Mood Disorders 3.7 1.9 0.95
multiple chemical sensitivity [MCS] 0.1 0.1
Multiple Sclerosis 2.2 2.3 -0.05
Multiple system atrophy (MSA) 0.1 0.1
myasthenia gravis 0.5 0.1 4
neuropathic pain 0.8 -0.8
Neuropathy (all types) 0.1 0.6 -5
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.2 0.6 2.67
NonCeliac Gluten Sensitivity 0.4 0.4 0
Obesity 3 2.7 0.11
obsessive-compulsive disorder 3.4 1 2.4
Osteoarthritis 1.5 0.5 2
Osteoporosis 1 0.5 1
pancreatic cancer 0.7 0.1 6
Parkinson's Disease 3.1 3 0.03
Polycystic ovary syndrome 3.9 1 2.9
Premenstrual dysphoric disorder 0.3 -0.3
primary biliary cholangitis 0.1 1 -9
Primary sclerosing cholangitis 1.2 0.8 0.5
Psoriasis 1.2 1.5 -0.25
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.8 1.5 0.87
Rosacea 0.1 -0.1
Schizophrenia 2 0.8 1.5
scoliosis 0.5 0.3 0.67
sensorineural hearing loss 0.1 0.1
Sjögren syndrome 1.1 1.3 -0.18
Sleep Apnea 0.5 0.6 -0.2
Slow gastric motility / Gastroparesis 0.9 0.9
Small Intestinal Bacterial Overgrowth (SIBO) 1.3 1.3
Stress / posttraumatic stress disorder 1.8 0.8 1.25
Systemic Lupus Erythematosus 2.6 0.7 2.71
Tic Disorder 0.7 0.6 0.17
Tourette syndrome 0.1 0.4 -3
Type 1 Diabetes 2.4 1.2 1
Type 2 Diabetes 4.4 4.1 0.07
Ulcerative colitis 3.5 4 -0.14
Unhealthy Ageing 3.2 0.5 5.4
Vitiligo 1.3 0.3 3.33

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]